Statement of Changes in Beneficial Ownership (4)
July 06 2015 - 7:31PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Vanlancker Thierry FJ
|
2. Issuer Name
and
Ticker or Trading Symbol
Chemours Co
[
CC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
President - Fluoroproducts
|
(Last)
(First)
(Middle)
1007 MARKET STREET
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/1/2015
|
(Street)
WILMINGTON, DE 19899
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, par value $.01
|
7/1/2015
|
|
A
|
|
138019
(1)
|
A
|
$0.00
|
140972
(2)
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (Right to Buy)
|
$11.8693
|
7/1/2015
|
|
A
(3)
|
|
32678
|
|
(4)
|
2/5/2020
|
Common Stock
|
32678
|
$0.00
|
32678
|
D
|
|
Stock Option (Right to Buy)
|
$15.4871
|
7/1/2015
|
|
A
(3)
|
|
25568
|
|
(5)
|
2/4/2021
|
Common Stock
|
25568
|
$0.00
|
25568
|
D
|
|
Stock Option (Right to Buy)
|
$18.4494
|
7/1/2015
|
|
A
(3)
|
|
30152
|
|
(6)
|
2/3/2022
|
Common Stock
|
30152
|
$0.00
|
30152
|
D
|
|
Explanation of Responses:
|
(
1)
|
Represents restricted stock units granted in accordance with the Employee Matters Agreement (the "Agreement") dated as of June 26, 2015 between the Issuer and E. I. du Pont de Nemours and Company ("DuPont") to replace restricted stock units and related dividend equivalent units of DuPont held by the Reporting Person immediately before the legal and structural separation of Issuer from DuPont (the "Spin-off").
|
(
2)
|
Includes shares of Issuer common stock received in connection with the Spin-off in an exempt transaction pursuant to Rule 16a-9 based on preliminary information regarding the Spin-off. Final amounts, if different, will be reported in a subsequent filing.
|
(
3)
|
Award replaces stock options of DuPont held by the Reporting Person immediately before the Spin-off pursuant to the Agreement. Information reported in this row is estimated as of July 6, 2015 based on preliminary information regarding the Spinoff. Final information, if different, will be reported in a subsequent filing.
|
(
4)
|
Includes 21,785 options to purchase shares of Issuer common stock that are immediately exercisable. The remaining options vest on February 6, 2016.
|
(
5)
|
Includes 8,523 options to purchase shares of Issuer common stock that are immediately exercisable. The remaining options vest in two approximately equal annual installments beginning February 5, 2016.
|
(
6)
|
Options to purchase shares of Issuer common stock vest in three approximately equal annual installments beginning February 4, 2016.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Vanlancker Thierry FJ
1007 MARKET STREET
WILMINGTON, DE 19899
|
|
|
President - Fluoroproducts
|
|
Signatures
|
/s/ Brian Morrissey, as attorney-in-fact for Thierry F.J. Vanlancker
|
|
7/6/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Chemours (NYSE:CC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chemours (NYSE:CC)
Historical Stock Chart
From Apr 2023 to Apr 2024